Clinical trial

A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

NCT02703324

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-03-01

PhasePHASE1

Study timeline

Study start (unknown)2016-03-01Date precision: month

Registry last updated2020-06-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

LY900014DRUG

Insulin LisproDRUG · verified · RxNorm: insulin lispro

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02703324 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.